9th European Regional Conference on Thoracic Oncology: New challenges in diagnosis and treatment

16-17 June 2017 Hotel „Holiday Inn Vilnius“ Vilnius, Lithuania

Preliminary Program

7:00 – 8:30 Young investigators Session Chairs: M. Moniuszko, S. Cicenas

NSCLC Vilnius, Lithuania07:00-07:10 Clinical potential of miRNAs and their targets in

NSCLC Julija Fadejeva Vilnius, Lithuania

07:10-07:20 Molecular profiling of lung cancer Magdalena Niemira Bialystok, Poland

07:20-07:30 Tumor infiltrating immune cells as biomarkers in NSCLC

Jaroslavas Bublevič Vilnius, Lithuania

07:30-07:40 Deciphering non-small cell lung cancer by -omics approach

Michał Ciborowski Bialystok, Poland

07:40-07:50 Intra-tumor genetic heterogeneity of lung adenocarcinoma as investigated by next generation sequencing

Mindaugas Morkūnas Vilnius, Lithuania

07:50-08:00 The role of miR-145 in regulation of immune response in lung cancer

Andrzej Eljaszewicz Bialystok, Poland

08:00-08:10 Three-dimensional spheroid cell culture as avascular tumor model for cancer research

Greta Jarockytė Vilnius, Lithuania

08:10-08:30 New Horizon 2020 based PhD studies Marcin Moniuszko Bialystok, Poland

08:00-9:00 Registration

Welcome address Moderation: S. Cicenas, J. Niklinski, Ch. Manegold

1. Lithuanian Minister of Health (SAM)2. Rector of Vilnius University (VU Rektorius)3. Dean of the Faculty of Medicine (MF dekanas)4. Deputy Director for Clinic (NVI Direktoriaus pavaduotojas klinikai )

Music introduction

9:30-10:30 Recent Advances in first line advanced squamous NSCLC (LQLC) treatment (Lilly session) Chairs: A. Cesas

Nicolas Thatcher United Kingdom

Frid

ay,

Jun

e 1

6,

201

7

10:30-11:00 New Biobanking and Omics analysis (The MOBIT Project) Session – Keynot Lecture Chairs: Ch. Manegold, S. Cicenas, J. Niklinski

10:30-10:40 Introduction to MOBIT Project Jacek Niklinski Bialystok, Poland

10:40-10:50 A novel approach to the Oncology Biobank and Omics analysis in the University setting

Anna Michalska-Falkowska Bialystok, Poland

10:50-11:00 Clinical value of PET/MRI in the management of lung cancer

Dorota Jurgilewicz Bialystok, Poland

11:00-11:15 Coffee break

11:15-12:00 Lung Cancer: New Imaging /Pathology/Molecular biology Chairs: G. Smailyte, M Papotti

11:15-11:30 New Imaging Wieland Voigt Erlangen, Germany

11:30-11:45 Pathology Mauro G Papotti Torino, Italy

11:45-12:00 Molecular biology Lukas Heukamp Hamburg, Germany

12:00-13:00 Gefitinib – A successful story and a value for the future (AstraZeneca session)

Chairs: S. Cicenas, E. Danila

Antonio M Araujo Porto, Portugal

13:00-14:00 Lunch

14:00-14:30 Surgery for lung cancer Chairs: S. Cicenas, M. Kozlowski

14:00-14:15 Broncho-vascular sleeve resections in patients with malignant pulmonary neoplasms: indications and results

Oleg Pikin Moscow, Russia

14:15-14:30 VATS in thoracic oncology Miroslaw Kozlowski Bialystok, Poland

14:30-14:50 Radiotherapy in lung cancer Chairs: R. Steponaviciene, A. Wrona

14:30-14:40 Stereotactic radiotherapy in the treatment of lung cancer - challenges and new perspectives

Anna Wrona Gdansk, Poland

Frid

ay,

Jun

e 1

6,

201

7

14:40-14:50 Radiation and Immunotherapy: How to combine? Francoise Mornex Lyon, France

14:50-15:10 Immunotherapy of lung cancer Chairs: R. Pirker, S. Baka

14:50-15:00 Immunotherapy for NSCLC – First Line Treatment Sofia Baka Thessaloniki, Greece

15:00-15:10 Immunotherapy of advanced non-small cell lung cancer: the potential of combinations

Robert Pirker Vienna, Austria

15:10-15:40 Coffee break

15:40-16:40 Treatment of advanced lung adenocarcinomas (Lilly session)

Chairs: A.Cesas

Jussi Koivunen Oulo, Finland

16:40-17:10 Modern treatment of early and advanced lung cancer, new clasiffication Chairs: L. Crino, E. Danila

16:40-16:55 Early cancer treatment Tadeusz Orlowski Warsaw, Poland

16:55-17:10 Advanced cancer treatment Lucio Crino Perugia, Italy

17:10-18:10 EGFR mutation positive lung cancer in Estonia: from testing to treatment (Boehringer-Ingelheim session) Chair: S. Cicenas

Jana Jaal

Tartu, Estonia

18:10-18:10 Tobaco control and Biostatistics Chairs: R. Everatt, L. Piltz

18:10-18:25 Smoking cessation in young people Anneke Buehler Munich, Germany

18:25-18:40 Stratification strategies for clinical lung trials Lothar R Pilz Mannheim, Germany

19:00 Dinner

Frid

ay,

Jun

e 1

6,

201

7

Vilnius, Lithuania09:00-10:30 Selected case reports

Chairs: S. Cicenas, M. Burmistrov, V.Zharkov

09:00-09:15

09:15-09:30

Long-term survival of patient after "salvage" surgery for oligometastatic NSCLC

Oleg Pikin Moscow, Russia

09:30-09:45 Replacement of trachea with tissue ingineering prosthesis

Demidchik Yuriy, Vladimir Zharkov Minsk, Belarus

09:45-10:00 Larynx-preserving Cervical Esophagectomy in Locally Advanced Esophageal Cancer

Andrey Rudyk , Mikhail Burmistrov Kazan, Russia

10:00-10:30 Discussion

10:30-11:00 Coffee break

11:00-11:15 A case of severe acquired thrombophilia associated with ROS1 positive lung adenocarcinoma

Viktors Kozirovskis Riga, Latvia

11:15-11:30 How important is follow up of the patient after resection of lung cancer

Wojciech Laudanski Bialystok, Poland

11:30-11:45 Successful combined treatment of malignant pleural and peritoneum mesotheloma

Rugile Cesaite, Alvydas Cesas Klaipėda, Liethuania

11:45-12:00 ALK-positive NSCLC: clinical cases Rossitza Krasteva Panagyurishte, Bulgaria

12:00-12:15 Long-term complex treatment of multiple metastatic adenocarcinoma of the lung

Andrey Akopov Saint Petersburg, Russia

12:15-12:30 Discussion

12:30 Closing remarks Moderation: S. Cicenas, J. Niklinski, Ch. Manegold

Sa

turd

ay,

Jun

e 1

7,

201

7

A case report of individualised treatment of oligometastatic disease.

Laura Norkiene NVI, Vilnius, Lithuania